Protagonist Therapeutics

+$0.17 (+0.50%) As of 3:27 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L.

CEO
Dinesh V. Patel
Employees
79
Headquarters
Newark, California
Founded
2006

PTGX Key Statistics

Market cap
1.62B
Price-Earnings ratio
—
Dividend yield
—
Average volume
417.69K
High today
$33.99
Low today
$33.36
Open price
$33.65
Volume
14.30K
52 Week high
$50.54
52 Week low
$12.80

PTGX Earnings

-$0.72
-$0.48
-$0.24
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure